DrugRisk Adds Latest NuvaRing Information As Trials Set to Begin
Dallas, TX (PRWEB) October 23, 2013 -- The birth control safety advocates at DrugRisk.com are announcing updated information for women using the contraceptive NuvaRing. A recent court report shows the number of lawsuits alleging the device caused blood clots increasing, and a federal judge has scheduled the first trial*.
DrugRisk is a free resource for those taking popular prescription drugs. By providing the latest updates on product recalls, safety alerts, research and litigation news, patients can avoid dangerous drugs, see if others are experiencing similar side effects and decide if they need legal advice.
The resource center has added warnings from health experts linking contraceptives like NuvaRing to higher risks of blood clots than traditional birth control pills. Last year, the New England Journal of Medicine published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots**.
Due to the number of patients who have filed a NuvaRing lawsuit alleging blood clots, many cases are now consolidated in a special federal multidistrict litigation court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri.
The latest court records show the number of cases filed has grown over 4% in less than a month from 1,358 claims on August 15th to 1,419 as of September 11***.
Now, DrugRisk has learned that U.S. District Judge Rodney Sippel, who is overseeing the litigation, has scheduled the first trial to start on January 27th*.
Lawyers are still helping those affected. Anyone who suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact the DrugRisk Center or speak with a lawyer about their legal rights as soon as possible. However, DrugRisk only recommends lawyers and law firms who have already handled NuvaRing lawsuits.
For more information on the research, side effects and litigation news related to NuvaRing and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.
*U.S. District Judge Rodney Sippel, 7/30/13; aboutlawsuits.com/wp-content/uploads/2013-07-30-NuvaRing-Order.pdf
**New England Journal of Medicine, 6/14/12; nejm.org/doi/full/10.1056/NEJMoa1111840
***JPML 9/11/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-September-11-2013.pdf
Chris Schroeder, DrugRisk, http://www.DrugRisk.com, 888-415-1859, [email protected]
Share this article